Clonality_NN
of_IN
isolated_VBN
eosinophils_NNS
in_IN
the_DT
hypereosinophilic_JJ
syndrome_NN
._.

The_DT
idiopathic_JJ
hypereosinophilic_JJ
syndrome_NN
-LRB-_-LRB-
IHES_NN
-RRB-_-RRB-
is_VBZ
a_DT
rare_JJ
disorder_NN
characterized_VBN
by_IN
unexplained_JJ
,_,
persistent_JJ
eosinophilia_NN
associated_VBN
with_IN
multiple_JJ
organ_NN
dysfunction_NN
due_JJ
to_TO
eosinophilic_JJ
tissue_NN
infiltration_NN
._.

In_IN
the_DT
absence_NN
of_IN
karyotypic_JJ
abnormalities_NNS
,_,
there_EX
is_VBZ
no_DT
specific_JJ
test_NN
to_TO
detect_VB
clonal_JJ
eosinophilia_NN
in_IN
IHES_NN
._.

Analysis_NN
of_IN
X-chromosome_NN
inactivation_NN
patterns_NNS
can_MD
be_VB
used_VBN
to_TO
determine_VB
whether_IN
proliferative_JJ
disorders_NNS
are_VBP
clonal_JJ
in_IN
origin_NN
._.

Methylation_NN
of_IN
HpaII_NN
and_CC
Hha_NN
I_CD
sites_NNS
near_IN
the_DT
polymorphic_JJ
trinucleotide_JJ
repeat_NN
of_IN
the_DT
human_JJ
androgen_NN
receptor_NN
gene_NN
-LRB-_-LRB-
HUMARA_NN
-RRB-_-RRB-
has_VBZ
been_VBN
shown_VBN
to_TO
correlate_VB
with_IN
X-inactivation_NN
._.

In_IN
this_DT
study_NN
,_,
we_PRP
have_VBP
used_VBN
the_DT
polymerase_NN
chain_NN
reaction_NN
-LRB-_-LRB-
PCR_NN
-RRB-_-RRB-
with_IN
nested_JJ
primers_NNS
to_TO
analyze_VB
X-inactivation_NN
patterns_NNS
of_IN
the_DT
HUMARA_NN
loci_NNS
in_IN
purified_VBN
eosinophils_NNS
from_IN
female_JJ
patients_NNS
with_IN
eosinophilia_NN
._.

Peripheral_JJ
blood_NN
eosinophils_NNS
were_VBD
isolated_VBN
by_IN
their_PRP$
autofluoresence_NN
using_VBG
flow_NN
cytometric_JJ
sorting_NN
._.

Eosinophils_NNS
purified_VBN
from_IN
a_DT
female_JJ
patient_NN
presenting_VBG
with_IN
IHES_NN
were_VBD
found_VBN
to_TO
show_VB
a_DT
clonal_JJ
pattern_NN
of_IN
X-inactivation_NN
._.

Eosinophil-depleted_JJ
leukocytes_NNS
from_IN
this_DT
patient_NN
were_VBD
polyclonal_JJ
by_IN
HUMARA_NN
analysis_NN
,_,
thus_RB
excluding_VBG
skewedness_NN
of_IN
random_JJ
X-inactivation_NN
._.

After_IN
corticosteroid_NN
suppression_NN
of_IN
her_PRP$
blood_NN
eosinophilia_NN
,_,
a_DT
clonal_JJ
population_NN
of_IN
eosinophils_NNS
could_MD
no_RB
longer_RBR
be_VB
detected_VBN
in_IN
purified_VBN
eosinophils_NNS
._.

In_IN
contrast_NN
,_,
eosinophils_NNS
purified_VBN
from_IN
a_DT
patient_NN
with_IN
Churg-Strauss_JJ
syndrome_NN
and_CC
from_IN
six_CD
patients_NNS
with_IN
reactive_JJ
eosinophilias_NNS
attributed_VBN
to_TO
allergy_NN
,_,
parasitic_JJ
infection_NN
,_,
or_CC
drug_NN
reaction_NN
showed_VBD
a_DT
polyclonal_JJ
pattern_NN
of_IN
X-inactivation_NN
by_IN
HUMARA_NN
analysis_NN
._.

The_DT
finding_NN
of_IN
clonal_JJ
eosinophilia_NN
in_IN
a_DT
patient_NN
presenting_VBG
with_IN
IHES_NN
indicates_VBZ
that_IN
such_JJ
patients_NNS
may_MD
have_VB
,_,
in_IN
reality_NN
,_,
a_DT
low-grade_JJ
clonal_JJ
disorder_NN
that_WDT
can_MD
be_VB
distinguished_VBN
from_IN
reactive_JJ
eosinophilias_NNS
by_IN
HUMARA_NN
analysis_NN
._.

Further_RB
,_,
the_DT
method_NN
described_VBN
can_MD
be_VB
used_VBN
to_TO
monitor_VB
disease_NN
progression_NN
._.

